Juno Diagnostics

About

Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.

San Diego,California,United States
11 - 50
https://junodx.com

Highlights

Details

Last Funding Type: Seed
Industries: Biotechnology,Health Care,Health Diagnostics
Founded date: Aug 1, 2017
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Juno Diagnostics, Inc.
Also Known As: Juno Dx

Juno Diagnostics is a health technology company democratizing access to high-value genetic information. The company is developing simple, cost-effective devices that enable point-of-need genetic testing.

It was founded in 2017 and is based in San Diego, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$25M

Juno Diagnostics has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on May 25, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 25, 2021	Series A	—	1	—	—	Detail
May 12, 2021	Series A	$25M	3	Perceptive Advisors	—	Detail
Jan 1, 2019	Seed	—	4	Zoic Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

8

Juno Diagnostics is funded by 8 investors. Perceptive Advisors and Zoic Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Perceptive Advisors	Yes	Series A
Zoic Capital	Yes	Seed
Bioverge	—	Series A
Charge Ventures	—	Series A
Milad Alucozai	—	Series A
Colle Capital Partners	—	Seed
Prototype Capital	—	Seed
Saltagen Ventures	—	Seed